Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vtama as add-on to biologics in psoriasis
NCT06103695Phase 4Completed
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Start
- Feb 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tapinarof in plaque psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Started Feb 2023; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06103695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06103695.